Last week, Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH) emerged as one of the top performers among micro- and small-cap firms in the stock market, surging by 46.7% despite the lack of fresh catalysts. The China-based company, which focuses on developing private skincare labels and direct skincare product sales, has seen its stock price rise by 92.25% since its debut on the US stock exchange in December 2024. The company raised $4.8 million from its IPO, with plans to expand its directly-owned stores, develop proprietary products, and reduce production costs by acquiring ingredient suppliers.
PHH’s impressive performance landed it in the 8th spot on our list of last week’s top performers. While we recognize the potential of PHH as an investment, we believe that there are other AI stocks with greater promise for delivering higher returns in a shorter time frame. If you are interested in exploring AI stocks that trade at less than 5 times their earnings, you can refer to our report on the cheapest AI stock available in the market.
Micro- and small-cap companies dominated the stock market last week, outperforming the Russell 2000 index which dropped by 4.04%. Among the top performers, Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH) stood out with its impressive gains, reflecting investor optimism in the company’s growth prospects.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.
